767
Views
1
CrossRef citations to date
0
Altmetric
Drug Profile

Dabrafenib and trametinib for the treatment of non-small cell lung cancer

Pages 1063-1068 | Received 25 Jan 2018, Accepted 05 Sep 2018, Published online: 13 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohamed Elbadawy, Yomogi Sato, Takashi Mori, Yuta Goto, Kimika Hayashi, Megumi Yamanaka, Daigo Azakami, Tsuyoshi Uchide, Ryuji Fukushima, Toshinori Yoshida, Makoto Shibutani, Mio Kobayashi, Yuta Shinohara, Amira Abugomaa, Masahiro Kaneda, Hideyuki Yamawaki, Tatsuya Usui & Kazuaki Sasaki. (2021) Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism. Cancer Biology & Therapy 22:5-6, pages 357-371.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.